Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors

G. J. Peters; G. J. Ossenkoppele; J. Cloos; G. Jansen

Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors

G. J. Peters, G. J. Ossenkoppele, J. Cloos, G. Jansen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	616-616
Journal	Amino Acids
Volume	48
Issue number	2
Publication status	Published - Feb 2016

Cite this

Peters, G. J., Ossenkoppele, G. J., Cloos, J., & Jansen, G. (2016). Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors. Amino Acids, 48(2), 616-616.

@article{570fda4fd5ae416f92d133635dd86ed8,

title = "Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors",

author = "Peters, {G. J.} and Ossenkoppele, {G. J.} and J. Cloos and G. Jansen",

year = "2016",

month = "2",

language = "English",

volume = "48",

pages = "616--616",

journal = "Amino Acids",

issn = "0939-4451",

publisher = "Springer Wien",

number = "2",

}

TY - JOUR

T1 - Protein degradation as a target for anticancer therapy: molecular mechanisms of efficacy and acquired resistance to proteasome and aminopeptidase inhibitors

AU - Peters, G. J.

AU - Ossenkoppele, G. J.

AU - Cloos, J.

AU - Jansen, G.

PY - 2016/2

Y1 - 2016/2

M3 - Article

VL - 48

SP - 616

EP - 616

JO - Amino Acids

JF - Amino Acids

SN - 0939-4451

IS - 2

ER -